营养传感器CRTC和Sarcalumenin/thinman代表了心脏缩的一个替代途径
Cristiana Dondi1, Georg Vogler1, Anjali Gupta1
1Development, Aging and Regeneration Program, Center for Genetic Disorders and Aging Research, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Cell reports
|August 2, 2024
概括
通过CREB调节的转录共激活剂 (CRTC) 在心脏缩中起着关键作用. 这项研究揭示了在多个模型系统中对心脏功能至关重要的一种保存的Calcineurin-CRTC-Sarcalumenin信号通路.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 已知氨酸 (CaN) 调节葡萄糖生成基因,并与心脏缩有关.
- 对于CREB调节的转录共激活剂 (CRTC) 在心脏功能中的作用,特别是在心脏缩方面,仍然在很大程度上未被探索.
研究的目的:
- 研究CRTC在心脏缩中的心脏自主作用.
- 阐明涉及CRTC在心脏功能中的分子机制和信号通路.
主要方法:
- 使用Drosophila melanogaster作为研究CRTC突变体和心脏特异性敲击/过度表达的模型系统.
- 在CRTC操纵的Drosophila心脏上进行RNA测序 (RNA-seq).
- 在斑马鱼和人类诱导心肌细胞中研究了CRTC的敲击.
主要成果:
- 在Drosophila的心脏中,CRTC突变和敲击显示了心脏限制,肌纤维细胞失调,纤维化和低心率.
- 在Drosophila中,心脏特异性的CRTC过度表达导致过度缩.
- 在CRTC突变体中,CaN诱导的缩减少,这表明CRTC的调解作用.
- RNA-seq确定了代谢基因失调,并突出显示了sarcalumenin (Srl) 作为下游目标.
- 在斑马鱼和人类心肌细胞中的CRTC操纵重复了心脏功能障碍,并影响了Srl表达和作用潜力的持续时间.
结论:
- CRTC在调节心脏缩方面发挥着重要的心脏自主作用.
- 一个涉及氨酸-CRTC-sarcalumenin的保存信号通路被确定为对心脏功能和缩至关重要的.
- 这一途径代表了理解和潜在治疗心脏病的新目标.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
The Sarcomere
7.8K
A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each...
Each...
7.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


